NanoViricides Inc. (NNVC) is a publicly traded Healthcare sector company. As of October 13, 2026, NNVC trades at $1.30 with a market cap of $33.18M and a P/E ratio of -3.23. NNVC moved +0.78% today. Year to date, NNVC is +13.27%; over the trailing twelve months it is -6.57%. Its 52-week range spans $0.85 to $2.23. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces NNVC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
1 analysts cover NNVC: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $6.00.
| Metric | Value |
|---|---|
| Price | $1.30 |
| Market Cap | $33.18M |
| P/E Ratio | -3.23 |
| EPS | $-0.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.23 |
| 52-Week Low | $0.85 |
| Volume | 35.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-8.22M |
| Gross Margin | 0.00% |
1 analysts cover NNVC: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.